Theraclion Past Earnings Performance

Past criteria checks 0/6

Theraclion has been growing earnings at an average annual rate of 4.3%, while the Medical Equipment industry saw earnings growing at 9.1% annually. Revenues have been declining at an average rate of 17.4% per year.

Key information

4.3%

Earnings growth rate

38.0%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate-17.4%
Return on equity-74.5%
Net Margin-260.9%
Last Earnings Update30 Jun 2023

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Theraclion makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:TCLI.F Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 232-530
31 Mar 232-530
31 Dec 221-530
30 Sep 221-550
30 Jun 221-540
31 Mar 221-430
31 Dec 211-430
30 Sep 212-410
30 Jun 212-420
31 Mar 211-420
31 Dec 201-420
30 Sep 201-430
30 Jun 202-420
31 Mar 203-420
31 Dec 193-420
30 Sep 193-440
30 Jun 192-410
31 Mar 192-520
31 Dec 182-630
30 Sep 182-620
30 Jun 183-640
31 Mar 183-640
31 Dec 173-630
30 Sep 173-640
30 Jun 172-640
31 Mar 172-640
31 Dec 162-740
30 Sep 162-740
30 Jun 162-740
31 Mar 162-740
31 Dec 152-640
30 Sep 151-630
30 Jun 150-630
31 Mar 151-530
31 Dec 141-520
30 Sep 141-520
30 Jun 141-420
31 Mar 140-420
31 Dec 130-420
31 Dec 120-310

Quality Earnings: TCLI.F is currently unprofitable.

Growing Profit Margin: TCLI.F is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: TCLI.F is unprofitable, but has reduced losses over the past 5 years at a rate of 4.3% per year.

Accelerating Growth: Unable to compare TCLI.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: TCLI.F is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.7%).


Return on Equity

High ROE: TCLI.F has a negative Return on Equity (-74.46%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.